Home Reimbursed medicines Nirsevimab

Nirsevimab — maximum prices and reimbursement

The CANAMED catalogue contains 6 medicines with the active substance Nirsevimab, from 1 manufacturer. Below you can see each entry with the brand name, the manufacturer, the maximum retail price and the prescription status — plus live pharmacy prices, where we track them.

6 CANAMED entries
1 Manufacturers
2044.16 Maximum price (RON)
Search live prices → All reimbursed medicines →

In short: for the active substance Nirsevimab there are 6 authorised medicines in the CANAMED catalogue, with a maximum retail price of 2044.16 RON, from 1 manufacturer. The reimbursement percentage depends on the CNAS sublist each product is placed on (A 90%, B 50%, C1/C2 100%, D 20%) and applies to the reference price, not to the shelf price. The maximum price is the legal cap — pharmacies may sell below it, so it is worth comparing the real price before you go. Latest import: 2026-11-03.

Data verified on from public sources (OpenStreetMap, chain websites, ANM/MS) — updated daily.

CANAMED catalogue

All medicines with Nirsevimab

Maximum retail price = the legal selling cap. Sorted by price, lowest first.

Brand name Manufacturer Maximum price Reimbursement Prescription
BEYFORTUS 100 mg ASTRAZENECA AB - SUEDIA 2044.16 RON not reimbursed PRF
BEYFORTUS 100 mg ASTRAZENECA AB - SUEDIA 2044.16 RON not reimbursed PRF
BEYFORTUS 50 mg ASTRAZENECA AB - SUEDIA 2044.16 RON not reimbursed PRF
BEYFORTUS 50 mg ASTRAZENECA AB - SUEDIA 2044.16 RON not reimbursed PRF
BEYFORTUS 100 mg ASTRAZENECA AB - SUEDIA — not reimbursed PRF
BEYFORTUS 50 mg ASTRAZENECA AB - SUEDIA — not reimbursed PRF

Prescription status key:

  • PRF — With a medical prescription kept by the pharmacy (P-RF)

This catalogue does not record the reimbursement percentage per product. Reimbursement is set through the CNAS sublists — A 90%, B 50%, C1/C2 100%, D 20% of the reference price — see the full explanation of the sublists or ask the pharmacist for the exact placement.

Live pharmacy prices

Products with Nirsevimab in our comparator

Shelf prices collected from the large chains — see on each product page where it is cheapest.

Good to know

How to read the maximum price

The CANAMED maximum retail price is the legal cap approved by the Ministry of Health — the pharmacy may sell for less, never for more. If the medicine is reimbursed, the sublist percentage (A 90%, B 50%, C1/C2 100%, D 20%) applies to the reference price of the therapeutic group, usually calculated from the cheapest product with the same INN — which is why your contribution can differ from one brand to another, even for the same active substance. The electronic prescription automatically shows the exact amount to pay; for non-prescription shelf prices, use the HartaFarmacii comparator.

CANAMED catalogue

Other active substances in the catalogue

See also the full list of reimbursed medicines, with an alphabetical index of all active substances.

Frequently asked questions

FAQ · Nirsevimab

  1. Is Nirsevimab reimbursed?
    Reimbursement for Nirsevimab depends on the CNAS sublist the prescribed product is placed on (A 90%, B 50%, C1/C2 100%, D 20%) and on the reference price of the therapeutic group — not on the shelf price. The electronic prescription automatically shows the sublist and your contribution; ask the doctor or pharmacist for your exact situation.
  2. What is the CANAMED maximum price for Nirsevimab?
    The maximum retail price (the CANAMED legal cap) for Nirsevimab is 2044.16 RON. It is the cap above which no pharmacy may sell — many sell below it, so it is worth comparing the real price with the HartaFarmacii comparator.
  3. What percentage of Nirsevimab is reimbursed?
    The percentage depends on the CNAS sublist: A 90% (common chronic diseases), B 50% (partial reimbursement), C1 and C2 100% (serious chronic diseases and national programmes), D 20%. The percentage applies to the reference price set by CNAS, not to the shelf price, so you may pay a difference even for a “100% reimbursed” medicine. You can see the exact placement on the electronic prescription.
  4. How many medicines with Nirsevimab are in the CANAMED catalogue?
    The CANAMED catalogue holds 6 authorised medicines with the active substance Nirsevimab — different brand names, strengths and pharmaceutical forms. You will find them all, with maximum price and prescription status, in the table on this page. Latest CANAMED import into the HartaFarmacii database: 2026-11-03.

Before you go

Find the best price for Nirsevimab

Compare prices →